The placebo effect and homeopathy

Homeopathy

Volumn 99, Issue 2, 2010, Pages 119-129

  Teixeira, Marcus Z ^a   Guedes, Cristina H F F ^a   Barreto, Patrícia V ^a   Martins, Mílton A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acupuncture; Conditioning; Expectation; Homeopathy; Imaging; Nocebo; Non specific effects; Placebo; qEEG; Specific effects

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; LITHIUM SALT; PLACEBO; RACLOPRIDE; REMIFENTANIL; RISPERIDONE;

ACUPUNCTURE; ALTERNATIVE MEDICINE; ANALGESIC ACTIVITY; ARTICLE; BIPOLAR MANIA; BRAIN DEPTH STIMULATION; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; CONDITIONING; DEPRESSION; DOCTOR PATIENT RELATION; ELECTROENCEPHALOGRAM; EVIDENCE BASED MEDICINE; EXPECTATION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HOMEOPATHY; HUMAN; MAJOR DEPRESSION; MEDLINE; NEUROMODULATION; NEUROPHYSIOLOGY; PAIN; PARKINSON DISEASE; PLACEBO EFFECT; PSYCHOPHYSIOLOGY; SYSTEMATIC REVIEW;

ACUPUNCTURE THERAPY; BRAIN; CLINICAL TRIALS AS TOPIC; DEPRESSIVE DISORDER, MAJOR; HOMEOPATHY; HUMANS; PAIN; PARKINSON DISEASE; PLACEBO EFFECT;

EID: 77952102427     PISSN: 14754916     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.homp.2010.02.001     Document Type: Article

References (83)

1. Hahnemann S. Organon of medicine. 6th edn. [Boericke W, Trans.] (1991), B Jain Publishers, New Delhi
2. Teixeira M.Z. Ensaio clínico quali-quantitativo para avaliar a eficácia e a efetividade do tratamento homeopático individualizado na rinite alérgica perene [tese] (Quali-quantitative clinical trial to evaluate the efficacy and the effectiveness of individualized homeopathic treatment in perennial allergic rhinitis (thesis)) (2009), School of Medicine, University of São Paulo, São Paulo. http://www.teses.usp.br/teses/disponiveis/5/5159/tde-10062009-102220/ Available from: http://www.teses.usp.br/teses/disponiveis/5/5159/tde-10062009-102220/
3. Teixeira M.Z. Bases psiconeurofisiológicas do fenômeno placebo-nocebo: evidências científicas que valorizam a humanização da relação médico-paciente (Psyconeurophysiologic bases of the placebo-nocebo phenomenon: scientific evidences that value the humanization of the doctor-patient relationship). Rev Assoc Med Bras 55 1 (2009) 13-18
4. Kaptchuk T.J., Kelley J.M., Conboy L.A., et al. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ 336 7651 (2008) 999-1003
5. Paterson C., and Dieppe P. Characteristic and incidental (placebo) effects in complex interventions such as acupuncture. BMJ 330 7501 (2005) 1202-1205
6. Benedetti F., Lanotte M., and Colloca L. When words are painful: unraveling the mechanisms of the nocebo effect. Neuroscience 147 2 (2007) 260-271
7. de Craen A.J., Kaptchuk T.J., Tijssen J.G., and Kleijnen J. Placebos and placebo effects in medicine: historical overview. J R Soc Med 92 10 (1999) 511-515
8. Su C., Lichtenstein G.R., Krok K., Brensinger C.M., and Lewis J.D. A meta-analysis of the placebo rates of remission and response in clinical trials of active Crohn's disease. Gastroenterology 126 5 (2004) 1257-1269
9. Cho H.J., Hotopf M., and Wessely S. The placebo response in the treatment of chronic fatigue syndrome: a systematic review and meta-analysis. Psychosom Med 67 2 (2005) 301-313
10. Patel S.M., Stason W.B., Legedza A., et al. The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil 17 3 (2005) 332-340
11. Ilnyckyj A., Greenberg H., and Bernstein C.N. Quantification of the placebo response in ulcerative colitis. Gastroenterology 112 6 (1997) 1854-1858
12. Walsh B.T., Seidman S.N., Sysko R., and Gould M. Placebo response in studies of major depression: variable, substantial, and growing. JAMA 287 14 (2002) 1840-1847
13. Sysko R., and Walsh B.T. A systematic review of placebo response in studies of bipolar mania. J Clin Psychiatry 68 8 (2007) 1213-1217
14. Macedo A., Baños J.E., and Farré M. Placebo response in the prophylaxis of migraine: a meta-analysis. Eur J Pain 12 1 (2008) 68-75
15. Hrobjartsson A., and Gotzsche P.C. Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment. J Intern Med 256 2 (2004) 91-100
16. Wampold B.E., Minami T., Tierney S.C., Baskin T.W., and Bhati K.S. The placebo is powerful: estimating placebo effects in medicine and psychotherapy from randomized clinical trials. J Clin Psychol 63 4 (2005) 373-377
17. Hunsley J., and Westmacott R. Interpreting the magnitude of the placebo effect: mountain or Molehill?. J Clin Psychol 63 4 (2007) 391-399
18. Tilburt J.C., Emanuel E.J., Kaptchuk T.J., Curlin F.A., and Miller F.G. Prescribing "placebo treatments": results of national survey of US internists and rheumatologists. BMJ 337 (2008) a1938
19. Geers A.L., Helfer S.G., Weiland P.E., and Kosbab K. Expectations and placebo response: a laboratory investigation into the role of somatic focus. J Behav Med 29 2 (2006) 171-178
20. de la Fuente-Fernandez R., Schulzer M., and Stoessl A.J. Placebo mechanisms and reward circuitry: clues from Parkinson's disease. Biol Psychiatry 56 2 (2004) 67-71
21. Olness K., and Ader R. Conditioning as an adjunct in the pharmacotherapy of lupus erythematosus. J Dev Behav Pediatr 13 2 (1992) 124-125
22. Goebel M.U., Trebst A.E., Steiner J., et al. Behavioral conditioning of immunosuppression is possible in humans. FASEB J 16 14 (2002) 1869-1873
23. Benedetti F., Amanzio M., Baldi S., Casadio C., and Maggi G. Inducing placebo respiratory depressant responses in humans via opioid receptors. Eur J Neurosci 11 2 (1999) 625-631
24. Benedetti F., Pollo A., Lopiano L., Lanotte M., Vighetti S., and Rainero I. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci 23 10 (2003) 4315-4323
25. Amanzio M., Pollo A., Maggi G., and Benedetti F. Response variability to analgesics: a role for non-specific activation of endogenous opioids. Pain 90 3 (2001) 205-215
26. Colloca L., Lopiano L., Lanotte M., and Benedetti F. Overt versus covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurol 3 11 (2004) 679-684
27. Amanzio M., and Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated subsystems. J Neurosci 19 1 (1999) 484-494
28. Vase L., Robinson M.E., Verne G.N., and Price D.D. Increased placebo analgesia over time in irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms. Pain 115 3 (2005) 338-347
29. Sauro M.D., and Greenberg R.P. Endogenous opiates and the placebo effect. A meta-analytic review. J Psychosom Res 58 2 (2005) 115-120
30. Petrovic P., Kalso E., Petersson K.M., and Ingvar M. Placebo and opioid analgesia - imaging a shared neural network. Science 295 5560 (2002) 1737-1740
31. Wager T.D., Rilling J.K., Smith E.E., et al. Placebo-induced changes in fMRI in the anticipation and experience of pain. Science 303 5561 (2004) 1162-1167
32. Price D.D., Craggs J., Verne G.N., Perlstein W.M., and Robinson M.E. Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients. Pain 127 1-2 (2007) 63-72
33. Fricchione G., and Stefano G.B. Placebo neural systems: nitric oxide, morphine and the dopamine brain reward and motivation circuitries. Med Sci Monit 11 5 (2005) MS54-MS65
34. Koyama T., McHaffie J.G., Laurienti P.J., and Coghill R.C. The subjective experience of pain: where expectations become reality. Proc Natl Acad Sci U S A 102 36 (2005) 12950-12955
35. Keltner J.R., Furst A., Fan C., Redfern R., Inglis B., and Fields H.L. Isolating the modulatory effect of expectation on pain transmission: a functional magnetic resonance imaging study. J Neurosci 26 16 (2006) 4437-4443
36. Kong J., Gollub R.L., Polich G., et al. A functional magnetic resonance imaging study on the neural mechanisms of hyperalgesic nocebo effect. J Neurosci 28 49 (2008) 13354-13362
37. Pollo A., Torre E., Lopiano L., Rizzone M., Lanotte M., and Cavanna A. Expectation modulates the response to subthalamic nucleus stimulation in Parkinsonian patients. Neuroreport 13 11 (2002) 1383-1386
38. de la Fuente-Fernandez R., Ruth T.J., Sossi V., Schulzer M., Calne D.B., and Stoessl A.J. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science 293 5532 (2001) 1164-1166
39. Kirsch I., Deacon B.J., Huedo-Medina T.B., Scoboria A., Moore T.J., and Johnson B.T. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the food and drug administration. PLoS Med 5 2 (2008) e45
40. Fournier J.C., DeRubeis R.J., Hollon S.D., et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 303 1 (2010) 47-53
41. Leuchter A.F., Cook I.A., Witte E.A., Morgan M., and Abrams M. Changes in brain function of depressed subjects during treatment with placebo. Am J Psychiatry 159 1 (2002) 122-129
42. Mayberg H.S., Silva J.A., Brannan S.K., et al. The functional neuroanatomy of the placebo effect. Am J Psychiatry 159 5 (2002) 728-737
43. Levine J.D., Gordon N.C., Bornstein J.C., and Fields H.L. Role of pain in placebo analgesia. Proc Natl Acad Sci U S A 76 7 (1979) 3528-3531
44. Benedetti F. The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia. Pain 64 3 (1996) 535-543
45. De Pascalis V., Chiaradia C., and Carotenuto E. The contribution of suggestibility and expectation to placebo analgesia phenomenon in an experimental setting. Pain 96 3 (2002) 393-402
46. Kirsch I., and Sapirstein G. Listening to Prozac but hearing placebo: a meta analysis of antidepressant medication. Prev Treat 1 2 (1998) ArtID 2a
47. McRae C., Cherin E., Yamazaki T.G., et al. Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial. Arch Gen Psychiatry 61 4 (2004) 412-420
48. Benedetti F., Amanzio M., and Maggi G. Potentiation of placebo analgesia by proglumide. Lancet 346 8984 (1995) 1231
49. Price D.D. Assessing placebo effects without placebo groups: an untapped possibility?. Pain 90 3 (2001) 201-203
50. Price D.D., Finniss D.G., and Benedetti F. A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol 59 (2007) 565-590
51. Eisenberg D.M., Kessler R.C., Foster C., Norlock F.E., Calkins D., and Delbanco T.L. Unconventional medicine in the United States: prevalence, costs and patterns use. N Engl J Med 328 4 (1993) 246-252
52. Eisenberg D.M., Davis R.B., Ettner S.L., et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 280 18 (1998) 1569-1575
53. Fisher P., and Ward A. Complementary medicine in Europe. BMJ 309 6947 (1994) 107-111
54. Burg M.A., Hatch R.L., and Neims A.H. Lifetime use of alternative therapy: a study of Florida residents. South Med J 91 12 (1998) 1126-1131
55. Molassiotis A., Scott J.A., Kearney N., et al. Complementary and alternative medicine use in breast cancer patients in Europe. Support Care Cancer 14 3 (2006) 260-267
56. Weyl Ben Arush M., Geva H., Ofir R., Mashiach T., Uziel R., and Dashkovsky Z. Prevalence and characteristics of complementary medicine used by pediatric cancer patients in a mixed western and middle-eastern population. J Pediatr Hematol Oncol 28 3 (2006) 141-146
57. Buettner C., Kroenke C.H., Phillips R.S., Davis R.B., Eisenberg D.M., and Holmes M.D. Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses' health study. Breast Cancer Res Treat 100 2 (2006) 219-227
58. Träger-Maury S., Tournigand C., Maindrault-Goebel F., et al. Use of complementary medicine by cancer patients in a French oncology department. Bull Cancer 94 11 (2007) 1017-1025
59. Laengler A., Spix C., Seifert G., Gottschling S., Graf N., and Kaatsch P. Complementary and alternative treatment methods in children with cancer: a population-based retrospective survey on the prevalence of use in Germany. Eur J Cancer 44 15 (2008) 2233-2240
60. Furnham A., and Forey J. The attitudes, behaviors, and beliefs of patients of conventional vs. complementary (alternative) medicine. J Clin Psychol 50 3 (1994) 458-469
61. Veeramah E.K., and Holmes S. Complementary therapy: complement or threat to modern medicine?. J R Soc Health 120 1 (2000) 42-46
62. Astin J.A. Why patients use alternative medicine: results of a national survey. JAMA 279 19 (1998) 1548-1553
63. Teixeira M.Z. Homeopatia: prática médica humanística (Homeopathy: a humanistic approach to medical practice). Rev Assoc Med Bras 53 6 (2007) 547-549
64. Van Wassenhoven M., and Ives G. An observational study of patients receiving homeopathic treatment. Homeopathy 93 1 (2004) 3-11
65. Thompson T.D., and Weiss M. Homeopathy - what are the active ingredients? An exploratory study using the UK Medical Research Council's framework for the evaluation of complex interventions. BMC Complement Altern Med 6 (2006) 37
66. Launsø L., Henningsen I., Rieper J., Brender H., Sandø F., and Hvenegaard A. Expectations and effectiveness of medical treatment and classical homeopathic treatment for patients with hypersensitivity illnesses -- one year prospective study. Homeopathy 96 4 (2007) 233-242
67. Marian F., Joost K., Saini K.D., von Ammon K., Thurneysen A., and Busato A. Patient satisfaction and side effects in primary care: an observational study comparing homeopathy and conventional medicine. BMC Complement Altern Med 8 (2008) 52
68. Pariente J., White P., Frackowiak R.S., and Lewith G.T. Expectancy and belief modulate the neuronal substrates of pain treated by acupuncture. Neuroimage 25 4 (2005) 1161-1167
69. Lewith G.T., White P.J., and Pariente J. Investigating acupuncture using brain imaging techniques: the current state of play. Evid Based Complement Alternat Med 2 3 (2005) 315-319
70. Bell I.R., Lewis II D.A., Schwartz G.E., et al. Electroencephalographic cordance patterns distinguish exceptional clinical responders with fibromyalgia to individualized homeopathic medicines. J Altern Complement Med 10 2 (2004) 285-299
71. Bell I.R., Lewis II D.A., Lewis S.E., et al. EEG alpha sensitization in individualized homeopathic treatment of fibromyalgia. Int J Neurosci 114 9 (2004) 1195-1220
72. Bausell R.B., Lao L., Bergman S., Lee W.L., and Berman B.M. Is acupuncture analgesia an expectancy effect? Preliminary evidence based on participants' perceived assignments in two placebo-controlled trials. Eval Health Prof 28 1 (2005) 9-26
73. Linde K., Witt C.M., Streng A., et al. The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. Pain 128 3 (2007) 264-271
74. Dorn S.D., Kaptchuk T.J., Park J.B., et al. A meta-analysis of the placebo response in complementary and alternative medicine trials of irritable bowel syndrome. Neurogastroenterol Motil 19 8 (2007) 630-637
75. Cherkin D.C., Sherman K.J., Avins A.L., et al. A randomized trial comparing acupuncture, simulated acupuncture, and usual care for chronic low back pain. Arch Intern Med 169 9 (2009) 858-866
76. Fisher P., McCarney R., Hasford C., and Vickers A. Evaluation of specific and non-specific effects in homeopathy: feasibility study for a randomised trial. Homeopathy 95 4 (2006) 215-222
77. Brien S., Lachance L., and Lewith G.T. Are the therapeutic effects of homeopathy attributed to the consultation, the homeopathic remedy, or both? A protocol for a future exploratory feasibility trial in patients with rheumatoid arthritis. J Altern Complement Med 10 3 (2004) 499-502
78. Bell I.R., Lewis II D.A., Brooks A.J., et al. Individual differences in response to randomly assigned active individualized homeopathic and placebo treatment in fibromyalgia: implications of a double-blinded optional crossover design. J Altern Complement Med 10 2 (2004) 269-283
79. Myers S.S., Phillips R.S., Davis R.B., et al. Patient expectations as predictors of outcome in patients with acute low back pain. J Gen Intern Med 23 2 (2008) 148-153
80. Bignamini M., Bertoli A., Consolandi A., et al. A controlled double-blind clinical study of 15 CH barium carbonate vs. placebo in a group of hypertensive inmates of 2 homes for the aged. Clin Ter 122 6 (1987) 429-436
81. Frei H., Everts R., von Ammon K., et al. Randomised controlled trials of homeopathy in hyperactive children: treatment procedure leads to an unconventional study design. Experience with open-label homeopathic treatment preceding the Swiss ADHD placebo controlled, randomised, double-blind, cross-over trial. Homeopathy 96 1 (2007) 35-41
82. Hill P.B., Hoare J., Lau-Gillard P., Rybnicek J., and Mathie R.T. Pilot study of the effect of individualised homeopathy on the pruritus associated with atopic dermatitis in dogs. Vet Rec 164 12 (2009) 364-370
83. University of Sao Paulo. Effectiveness of individualized homeopathic treatment in perennial allergic rhinitis. National Institutes of Health Clinical Trials Registry (ClinicalTrials.gov identifier: NCT00822406). Available from: http://clinicaltrials.gov/ct2/show/NCT00822406.